
DocGo Inc
Health Care · USD
Price
$0.539
Cap
$57M
Earnings
0/3 beat
30d Trend
+12%
Near 52-week lows — potential value or falling knife
Target range: $1 – $3 (consensus: $2.38)
Consensus: Buy
Earnings history
Q4 2025
MISS
-1.37 vs -0.24
Q3 2025
MISS
-0.11 vs -0.09
Q2 2025
MISS
-0.11 vs -0.03
Key macro factors
Inflation (US Inflation to 3.3%) and 'Higher for Longer' Rates: DocGo, as a healthcare services provider, faces increased operating costs due to inflation (e.g., fuel for transportation, wages for staff, medical supplies). Higher interest rates may also increase borrowing costs for expansion or operational needs, impacting profitability.
Q1 2026 Earnings Season Kicks Off: DocGo's performance will be viewed in the context of broader healthcare sector earnings. Concerns regarding the wind-down of migrant-related revenue, a significant factor in recent quarters, mean overall sector health and comparable company performance will be key indicators for investors.
Strait of Hormuz Closure Sustains Oil Price Volatility: DocGo's Transportation Services segment, including ambulance and non-emergency medical transport, is directly vulnerable to fluctuations in oil prices. Sustained volatility or increases in fuel costs could significantly impact operational expenses and reduce profit margins.
DocGo Inc. is a provider of technology-enabled mobile health and medical transportation services in the United States and the United Kingdom.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
